O Shaughnessy Asset Management LLC Purchases 18,058 Shares of Corteva, Inc. (NYSE:CTVA)

O Shaughnessy Asset Management LLC grew its stake in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 11.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 176,491 shares of the company's stock after purchasing an additional 18,058 shares during the period. O Shaughnessy Asset Management LLC's holdings in Corteva were worth $10,053,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of CTVA. Townsquare Capital LLC grew its position in Corteva by 13.1% during the 3rd quarter. Townsquare Capital LLC now owns 29,739 shares of the company's stock worth $1,748,000 after purchasing an additional 3,449 shares in the last quarter. Public Sector Pension Investment Board grew its position in Corteva by 11.3% in the third quarter. Public Sector Pension Investment Board now owns 29,502 shares of the company's stock worth $1,734,000 after acquiring an additional 3,000 shares in the last quarter. Verition Fund Management LLC lifted its stake in shares of Corteva by 8.5% in the 3rd quarter. Verition Fund Management LLC now owns 69,153 shares of the company's stock valued at $4,066,000 after purchasing an additional 5,426 shares during the last quarter. Erste Asset Management GmbH bought a new stake in Corteva in the third quarter worth $808,000. Finally, Benjamin Edwards Inc. increased its position in Corteva by 64.9% during the third quarter. Benjamin Edwards Inc. now owns 8,528 shares of the company's stock worth $502,000 after buying an additional 3,357 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company's stock.

Remove Ads

Insider Activity at Corteva

In related news, insider Brian Titus sold 26,560 shares of the business's stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total value of $1,692,934.40. Following the sale, the insider now owns 11,347 shares of the company's stock, valued at $723,257.78. The trade was a 70.07 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.14% of the stock is currently owned by insiders.

Corteva Stock Performance

Corteva stock traded down $5.64 during trading hours on Friday, hitting $55.66. The stock had a trading volume of 6,391,602 shares, compared to its average volume of 3,247,942. Corteva, Inc. has a fifty-two week low of $50.01 and a fifty-two week high of $66.24. The company has a market cap of $38.02 billion, a PE ratio of 43.15, a price-to-earnings-growth ratio of 1.68 and a beta of 0.73. The company has a 50-day moving average of $62.36 and a two-hundred day moving average of $60.29. The company has a quick ratio of 0.93, a current ratio of 1.45 and a debt-to-equity ratio of 0.08.

Corteva (NYSE:CTVA - Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. On average, equities research analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were given a dividend of $0.17 per share. The ex-dividend date was Monday, March 3rd. This represents a $0.68 annualized dividend and a dividend yield of 1.22%. Corteva's dividend payout ratio (DPR) is currently 52.71%.

Analysts Set New Price Targets

Several analysts have recently issued reports on CTVA shares. BNP Paribas upgraded Corteva to a "hold" rating in a research note on Monday, February 10th. KeyCorp upped their target price on Corteva from $68.00 to $70.00 and gave the stock an "overweight" rating in a research report on Friday, February 7th. Argus raised shares of Corteva from a "hold" rating to a "buy" rating and set a $69.00 price target on the stock in a research report on Monday, March 31st. UBS Group decreased their price objective on shares of Corteva from $74.00 to $73.00 and set a "buy" rating for the company in a report on Friday, January 10th. Finally, Oppenheimer lifted their target price on shares of Corteva from $70.00 to $72.00 and gave the stock an "outperform" rating in a report on Friday, February 7th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $68.06.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.